Jebus dude you gotta chill, all I was stating is that the price will fluctuate around 9.75, hence the " floating base ". they have a strong pipeline, partnerships, institutional ownership, catalysts and some insider buying....therefor I dont see significant downside, but not much upside either for a bit. Hopefully that clears it up for ya wise guy
The way its trading, how much its advanced in a short amount of time, big funds want cheaper shares, a bunch of pumping going on etc, new faces on board with multiple aliases
be an interesting couple weeks
nice big buys
to my fellow longs etc, the current institutional ownership is dismal, I love INO's potential and will be long for a few years...but don't kid yourself at this point with regards to ownership. wait for next 13f's
I generally invest in Biotech or wherever I see value and insider buying. I'm not an accountant but their growth, net income and eps all seem great....why the low price, why under the radar? I know I'm not smarter then the market and the majority of full time investors, so any thoughts?
Handyman and 2003, you guys got some balls....thats a nice chunk of change, and Potential, whats your guys avg price? I'm tempted to pick up more!